Performance Evaluation of RapiSure (EDGC) COVID-19 S1 RBD IgG/Neutralizing Ab Test for the Rapid Detection of SARS-CoV-2 Antibodies

The accurate detection of anti-neutralizing SARS-CoV-2 antibodies can aid in the understanding of the development of protective immunity against COVID-19. This study evaluated the diagnostic performance of the RapiSure (EDGC) COVID-19 S1 RBD IgG/Neutralizing Ab Test. Using the 90% plaque reduction n...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ha Nui, Yoon, Jung, Jang, Woong Sik, Lim, Chae Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955181/
https://www.ncbi.nlm.nih.gov/pubmed/36832131
http://dx.doi.org/10.3390/diagnostics13040643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955181/
https://www.ncbi.nlm.nih.gov/pubmed/36832131
http://dx.doi.org/10.3390/diagnostics13040643

Ejemplares similares